X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (62) 62
index medicus (59) 59
female (40) 40
male (35) 35
pathology (32) 32
child (27) 27
article (26) 26
oncology (26) 26
adult (25) 25
cancer (25) 25
tumors (23) 23
pediatrics (22) 22
adolescent (21) 21
immunohistochemistry (20) 20
diagnosis (18) 18
middle aged (18) 18
young adult (18) 18
child, preschool (15) 15
children (15) 15
analysis (13) 13
in situ hybridization, fluorescence (13) 13
mutation (13) 13
expression (12) 12
health aspects (12) 12
surgery (12) 12
cell biology (11) 11
mutations (11) 11
research (11) 11
aged (10) 10
animals (10) 10
chemotherapy (10) 10
diagnosis, differential (10) 10
melanoma (10) 10
usage (10) 10
genetic aspects (9) 9
genomics (9) 9
infant (9) 9
mice (9) 9
osteosarcoma (9) 9
sarcoma (9) 9
telomerase - genetics (9) 9
treatment outcome (9) 9
abridged index medicus (8) 8
aged, 80 and over (8) 8
biomarkers, tumor - analysis (8) 8
care and treatment (8) 8
melanoma - genetics (8) 8
metastasis (8) 8
patients (8) 8
prognosis (8) 8
risk factors (8) 8
carcinoma (7) 7
dna-binding proteins - genetics (7) 7
gene expression regulation, neoplastic (7) 7
magnetic resonance imaging (7) 7
metastases (7) 7
neuroblastoma (7) 7
adolescents (6) 6
biomarkers, tumor - genetics (6) 6
biomarkers, tumor - metabolism (6) 6
childhood (6) 6
epigenetics (6) 6
gene (6) 6
gene expression (6) 6
genes (6) 6
genomes (6) 6
hematology (6) 6
medicine & public health (6) 6
retrospective studies (6) 6
skin neoplasms - genetics (6) 6
adenoma, pleomorphic - genetics (5) 5
biopsy (5) 5
bone neoplasms - pathology (5) 5
children & youth (5) 5
disease-free survival (5) 5
dna methylation (5) 5
experience (5) 5
neoplasms (5) 5
rhabdomyosarcoma (5) 5
rna sequencing (5) 5
skin neoplasms - pathology (5) 5
survival (5) 5
tomography, x-ray computed (5) 5
tumor (5) 5
young adults (5) 5
adults (4) 4
biocompatibility (4) 4
bone neoplasms - surgery (4) 4
breast-cancer (4) 4
cell line, tumor (4) 4
childrens oncology group (4) 4
computed tomography (4) 4
cutaneous melanoma (4) 4
dermatology (4) 4
epigenomics (4) 4
gene amplification (4) 4
genetic research (4) 4
lung neoplasms - secondary (4) 4
management (4) 4
medicine, research & experimental (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatric blood & cancer, ISSN 1545-5009, 2/2018, Volume 65, Issue 2
The clinicopathologic features of pediatric melanoma are distinct from those of the adult counterpart. For example, most childhood melanomas exhibit a uniquely... 
giant congenital nevi | childhood melanoma | Pediatric melanoma | spitzoid melanoma | melanoma arising in association with large
Journal Article
Journal Article
Nature, ISSN 0028-0836, 01/2012, Volume 481, Issue 7381, pp. 329 - 334
Retinoblastoma is an aggressive childhood cancer of the developing retina that is initiated by the biallelic loss of RB1. Tumours progress very quickly... 
ANEUPLOIDY | CELLS | GENE | TYROSINE KINASE | MCL-1 | MULTIDISCIPLINARY SCIENCES | GROWTH | TUMOR | SYK INHIBITOR | CANCER | Retinoblastoma - genetics | Protein-Tyrosine Kinases - metabolism | Genomics | Humans | Retinoblastoma - drug therapy | Gene Expression Regulation, Neoplastic | Aneuploidy | Intracellular Signaling Peptides and Proteins - metabolism | Genes, Retinoblastoma - genetics | Molecular Targeted Therapy | Retinoblastoma - pathology | Protein-Tyrosine Kinases - genetics | Cell Death - drug effects | Intracellular Signaling Peptides and Proteins - genetics | Syk Kinase | Cell Line | Cell Survival - drug effects | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Retinoblastoma Protein - deficiency | Mutation - genetics | Sequence Analysis, DNA | Xenograft Model Antitumor Assays | Chromosomal Instability - genetics | Animals | Epigenesis, Genetic - genetics | Protein Kinase Inhibitors - therapeutic use | Retinoblastoma Protein - genetics | Mice | Protein Kinase Inhibitors - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | Gene mutations | Development and progression | Genetic aspects | Diagnosis | Research | Retinoblastoma | Gene therapy | Health aspects | Risk factors | Studies | Human subjects | Epigenetics | DNA methylation | Genomes | Mutation | Kinases | Experiments | Chromosomes | Cancer | Children & youth | Apoptosis
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 03/2012, Volume 307, Issue 10, pp. 1062 - 1071
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 2395 - 2395
Journal Article
Nature, ISSN 0028-0836, 09/2017, Volume 549, Issue 7670, pp. 96 - 100
Paediatric solid tumours arise from endodermal, ectodermal, or mesodermal lineages(1). Although the overall survival of children with solid tumours is 75%,... 
MULTIPLE-MYELOMA | HETEROGENEITY | BIOBANK | GENOMIC LANDSCAPE | MODELS | MULTIDISCIPLINARY SCIENCES | BORTEZOMIB | INHIBITOR | CANCER | DISCOVERY | PANOBINOSTAT LBH589 | Vincristine - pharmacology | Pyrazoles - therapeutic use | Epigenesis, Genetic | Heterografts - drug effects | Humans | Heterografts - metabolism | Bortezomib - pharmacology | Cell Cycle Proteins - antagonists & inhibitors | Neoplasms - genetics | Female | Indoles - pharmacology | Rhabdomyosarcoma - drug therapy | Clone Cells | Drug Therapy, Combination | Child | Heterografts - pathology | Hydroxamic Acids - pharmacology | Camptothecin - analogs & derivatives | High-Throughput Screening Assays - methods | Pyrazoles - pharmacology | Camptothecin - therapeutic use | Pyrimidines - pharmacology | Xenograft Model Antitumor Assays - methods | Neoplasms - drug therapy | Animals | Bortezomib - therapeutic use | Pyrimidines - therapeutic use | Nuclear Proteins - antagonists & inhibitors | Heterografts - transplantation | Vincristine - therapeutic use | Hydroxamic Acids - therapeutic use | Indoles - therapeutic use | Mice | Rhabdomyosarcoma - genetics | Camptothecin - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | Tumors in children | Care and treatment | Diagnosis | Xenotransplantation | Methods | Pediatrics | Rhabdomyosarcoma | Multiple myeloma | Genomes | Neuroblastoma | Gene expression | Vincristine | Patients | Children & youth | Irinotecan | Chemotherapy | Autopsy | Xenografts | Mutation | Children | Cancer | Tumors
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 03/2015, Volume 135, Issue 3, pp. 816 - 823
Journal Article
Histopathology, ISSN 0309-0167, 08/2013, Volume 63, Issue 2, pp. 250 - 262
AimsSalivary duct carcinoma (SDC) often arises in pleomorphic adenoma (PA). Putative precursors, including low-grade cribriform cystadenocarcinoma (LGCCC) and... 
low‐grade cribriform cystadenocarcinoma | ductal carcinoma | PLAG1 | salivary duct carcinoma | precursor | HMGA2 | pleomorphic adenoma | in situ | Ductal carcinoma in situ | Low-grade cribriform cystadenocarcinoma | Salivary duct carcinoma | Pleomorphic adenoma | Precursor | EX-PLEOMORPHIC ADENOMA | SCLEROSING POLYCYSTIC ADENOSIS | PAROTID-GLAND | GRADE CRIBRIFORM CYSTADENOCARCINOMA | IN-SITU HYBRIDIZATION | PATHOLOGY | INTRADUCTAL CARCINOMA | CELL BIOLOGY | ductal carcinoma in situ | GENE | low-grade cribriform cystadenocarcinoma | GROWTH | EXPRESSION | Adenoma, Pleomorphic - genetics | Immunohistochemistry | Carcinoma, Ductal - genetics | Salivary Gland Neoplasms - genetics | Carcinoma, Ductal - pathology | Humans | Middle Aged | Actins - metabolism | Male | Adenoma, Pleomorphic - metabolism | Cystadenocarcinoma - metabolism | Carcinoma in Situ - genetics | HMGA2 Protein - genetics | Salivary Gland Neoplasms - metabolism | Aged, 80 and over | Adult | Female | Carcinoma, Ductal - metabolism | Membrane Proteins - metabolism | Carcinoma in Situ - pathology | In Situ Hybridization, Fluorescence | Keratin-14 - metabolism | DNA-Binding Proteins - genetics | Cystadenocarcinoma - pathology | Gene Amplification | Salivary Ducts | Cystadenocarcinoma - genetics | Adenoma, Pleomorphic - pathology | Gene Rearrangement | Aged | Carcinoma in Situ - metabolism | Salivary Gland Neoplasms - pathology | Fluorescence | Chromosomal proteins | Carcinoma | Muscle proteins | Analysis | Cancer | Medical research
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14_Supplement, pp. 2730 - 2730
Telomerase reverse transcriptase (TERT) promoter mutations occur at a high frequency in melanoma, but the functional consequences of these mutations in... 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2730 - 2730
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 09/2019, p. 1
Spitz melanoma is a rare variant of melanoma defined by distinct clinical, histologic, and genetic features and affecting patients of all ages. Half of these... 
Journal Article